市場調查報告書

氫離子幫浦阻斷劑的全球市場 - 各類型·不同症狀·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析

Proton Pump Inhibitors Market, by Type, by Disease Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968769
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
氫離子幫浦阻斷劑的全球市場 - 各類型·不同症狀·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析 Proton Pump Inhibitors Market, by Type, by Disease Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月08日內容資訊: 英文 175 Pages
簡介

在眾多仿製藥的推出以及研發活動的發展等因素的支持下,預計全球氫離子幫浦阻斷劑市場將繼續大幅增長。

本報告提供全球氫離子幫浦阻斷劑 (PPI)的市場相關分析,提供產品概要和市場基本結構,主要的促進·阻礙因素,整體市場規模預測 (以金額為準,過去4年·今後8年份),各類型·不同症狀·各流通管道·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃,新型冠狀病毒感染疾病 (COVID-19)的影響等調查。

目錄

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場力學·規定·趨勢分析

  • 市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 影響度分析
  • 技術進步
  • 法規方案
  • 近幾年主要的動向
  • 事業聯盟/企業收購
  • 診斷率
  • 開發平台分析
  • PEST分析
  • 醫療費償付方案

第4章 全球氫離子幫浦阻斷劑市場:COVID-19感染擴大的影響

  • COVID-19的影響
  • 經濟影響
  • 供需趨勢的影響分析

第5章 全球氫離子幫浦阻斷劑市場:各類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期相比成長率 (YoY)的分析
  • 各市場區隔趨勢
    • Omeprazole
      • 簡介
      • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準)
    • Pantaprazole
    • Rabeprazole
    • Dexlansoprazole
    • Lansoprazole
    • 其他

第6章 全球氫離子幫浦阻斷劑市場:不同症狀

  • 市場區隔趨勢
    • 潰瘍
    • 胃食道逆流症 (GERD)
    • 其他

第7章 全球氫離子幫浦阻斷劑市場:各流通管道

  • 市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 其他

第8章 全球氫離子幫浦阻斷劑市場:各地區

  • 簡介
  • 市場佔有率分析
  • 與前一年同期相比成長率 (YoY)的分析
  • 北美
    • 簡介
    • 市場規模與其預測:各類型
    • 市場規模與其預測:不同症狀
    • 市場規模與其預測:各流通管道
    • 市場規模與其預測:各國
      • 美國
      • 加拿大
  • 南美
    • 市場規模與其預測:各國
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他的南美各國
  • 歐洲
    • 市場規模與其預測:各國
      • 德國
      • 英國
      • 義大利
      • 西班牙
      • 俄羅斯
      • 其他的歐洲各國
  • 亞太地區
    • 市場規模與其預測:各國
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • 東南亞國協
      • 其他的亞太地區各國
  • 中東
    • 市場規模與其預測:各國
      • 波灣合作理事會 (GCC) 各國
      • 以色列
      • 其他的中東各國
  • 非洲
    • 市場規模與其預測:各國
      • 北部非洲
      • 中部非洲
      • 非洲南部

第9章 競爭情形

  • 企業簡介
    • AstraZeneca PLC/AB
      • 企業概要
      • 產品系列
      • 財務實際成果
      • 近幾年的主要趨勢
      • 市場策略
    • Bayer AG
    • Pfizer Inc
    • Cadila Pharmaceuticals Limited
    • Eisai Pharmaceuticals India Pvt. Ltd
    • Santarus, Inc.
    • Wyeth, LLC
    • Janssen Pharmaceutica
    • Takeda Pharmaceutical Company Limited
    • Sanofi SA
    • Aurobindo Pharma
    • Perrigo Company plc
    • Dr. Reddy's Laboratories
    • Aralez Pharmaceuticals Inc.
    • RedHill Biopharma Ltd (ADR)
    • Cipla Limited
目錄

Title:
Proton Pump Inhibitors Market, by Type (Omeprazole, Pantaprazole, Rabeprazole, Dexlansoprazole, lansoprazole, and Others), by Disease Indication (Ulcers, Gastroesophageal Reflux Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

The global proton pump inhibitor market includes various drugs which are prescribed by healthcare professionals for treatments related to various gastrointestinal disorders such as duodenal ulcers, peptic ulcers, NSAIDS induced ulcers, and gasteroesophageal reflux disease. Proton pump inhibitors are a class of drugs that act on cell lining of stomach and reduce stomach acid in patients suffering from gastro-intestinal disorders. Proton pump inhibitors include drugs such as esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazol.

Market Dynamics

The global proton pump inhibitor market is expected to witness significant growth during the forecast period owing to focus of generic drug manufactures on obtaining approvals and launching products for treatment of gastro-intestinal diseases to strengthen their position in the global proton inhibitor market. For instance, in March 2020, Rosemont Pharmaceuticals, a pharmaceutical company, launched omeprazole powder for oral suspension, PPI approved for use on mg/kg basis and used in treatment of patients in age groups such as pediatric, adults. The omeprazole powder oral suspension is also licensed for use with percutaneous endoscopic gastonomy (PEG) and nasograstic (NG) tubes.

Key features of the study:

  • This report provides in-depth analysis of the global proton pump inhibitor market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global proton pump inhibitor market based on the following parameters - company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are AstraZeneca PLC/AB, Bayer AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Eisai Pharmaceuticals India Pvt. Ltd, Santarus, Inc., Wyeth, LLC, Janssen Pharmaceutica, Takeda Pharmaceutical Company Limited, Sanofi S.A., Aurobindo Pharma, Perrigo Company plc, Dr. Reddy's Laboratories
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, market expansion, and marketing tactics
  • The global proton pump inhibitor market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton pump inhibitor market.

Detailed Segmentation:

  • Global Proton Pump Inhibitor Market, By Type:
    • Omeprazole
    • Pantaprazole
    • Rabeprazole
    • Dexlansoprazole
    • lansoprazole
    • Others
  • Global Proton Pump Inhibitor Market, By Disease Indication:
    • Ulcers
    • Gastroesophageal Reflux Disease
    • Others
  • Global Proton Pump Inhibitor Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Others
  • Global Proton Pump Inhibitor Market, By Region:
    • North America
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Omeprazole
      • Pantaprazole
      • Rabeprazole
      • Dexlansoprazole
      • lansoprazole
      • Others
      • By Disease Indication:
      • Ulcers
      • Gastroesophageal Reflux Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • AstraZeneca PLC/AB *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novo Nordisk A/S
    • Bayer AG
    • Pfizer Inc.
    • Cadila Pharmaceuticals Limited
    • Eisai Pharmaceuticals India Pvt. Ltd
    • Santarus, Inc.
    • Wyeth, LLC
    • Janssen Pharmaceutica
    • Takeda Pharmaceutical Company Limited
    • Sanofi S.A.
    • Aurobindo Pharma
    • Perrigo Company plc
    • Dr. Reddy's Laboratories
    • Aralez Pharmaceuticals Inc.
    • RedHill Biopharma Ltd (ADR)
    • Cipla Limited
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Disease Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Technological Evolution
  • Regulatory Scenario
  • Key Developments
  • Collaboration and Acquisition
  • Diagnosis Rate/Ratio
  • Pipeline Analysis
  • PEST Analysis
  • Reimbursement Scenario

4. Global Proton Pump Inhibitors Market, Impact of COVID-19 Pandemic

  • COVID-19 Impact
  • Economic Impact
  • Demand and Supply Impact Analysis

5. Global Proton Pump Inhibitors Market, By Type, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Omeprazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Pantaprazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Rabeprazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Dexlansoprazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Lansoprazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

6. Global Proton Pump Inhibitors Market, By Disease Indication, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Gastesophageal Reflux Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

7. Global Proton Pump Inhibitors Market, By Distribution Channel, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

8. Global Proton Pump Inhibitors Market, By Region, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • AstraZeneca PLC/AB
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eisai Pharmaceuticals India Pvt. Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Santarus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Wyeth, LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Janssen Pharmaceutica
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurobindo Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Perrigo Company plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aralez Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • RedHill Biopharma Ltd (ADR)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies